GlassScriptPhysician profile
Shannon E Gleason
NPI 1366095820
$4,995.52
in general payments reported to CMS, 2019-2025
42 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $916 · 2022: $1,134 · 2023: $761 · 2024: $1,144 · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,865 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,865.43 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $799.97 | 2021-2025 | Repatha, Tepezza, Otezla |
| Janssen Pharmaceuticals, INC | $646.25 | 2021-2023 | Xarelto |
| Novo Nordisk INC | $515.00 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.56 | 2021-2025 | Jardiance |
| Insulet Corporation | $281.19 | 2024-2025 | Omnipod |
| Novartis Pharmaceuticals Corporation | $260.26 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $234.34 | 2021-2023 | Farxiga |
| Corcept Therapeutics | $215.99 | 2024-2025 | Korlym |
| Shield Therapeutics INC | $152.87 | 2023-2025 | Accrufer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.97 | 2021-2023 | Lifevest |
| Phathom Pharmaceuticals, INC. | $125.16 | 2024-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $124.16 | 2022-2023 | |
| Esperion Therapeutics, INC. | $113.88 | 2021-2023 | Nexletol |
| Lilly USA, LLC | $106.62 | 2023-2025 | Jardiance, Zepbound, Baqsimi |
| E.R. Squibb & Sons, L.L.C. | $105.25 | 2021-2023 | Camzyos, Eliquis |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Gleason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.